HBIO — HARVARD BIOSCIENCE INC

—
Nasdaq · Unknown · Unknown · CIK 1123494 ·
Last close
$9.08
Market Cap
$41.52M
52W High
$10.20
52W Low
$4.00
ADV30
24,951
Next earnings
2026-11-10
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 22,196,000 12,307,000 -492,000 -2,623,000 75,299,000 4,856,000 70,194,000
Jun 2026 22,727,000 12,630,000 -660,000 -2,910,000 76,286,000 6,503,000 68,868,000
Mar 2026 20,755,000 12,244,000 -939,000 -3,424,000 77,938,000 7,098,000 67,892,000
Dec 2025 23,735,000 14,172,000 1,927,000 -2,847,000 80,071,000 8,614,000 66,337,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-681,000
Investing CF
$-3,478,000
Financing CF
$2,357,000
CapEx
$-3,478,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.59
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-223,667,000
Inventory
$23,491,000
Receivables
$14,912,000
ST Investments
—
EBIT TTM
$-4,440,000
Pretax Income TTM
$-12,102,000
Interest Exp TTM
$7,662,000
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$89,413,000
EBITDA
$5,562,000
Free Cash Flow
$4,475,875
Enterprise Value
$80,679,224
Total Cash
$4,856,000
Total Debt
$42,594,000
Shares Out
4,573,080
Trailing EPS
$-2.59
Book Value
$1.12
ROE
-123.1%
ROA
0.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 86,550,000 100,000 -56,700,000 80,071,000 66,337,000 13,734,000 6,729,000
Dec 2024 94,135,000 -6,211,000 -12,405,000 126,644,000 63,304,000 63,340,000 1,440,000
Dec 2023 112,250,000 1,894,000 -3,415,000 137,366,000 64,292,000 73,074,000 14,028,000
Dec 2022 113,335,000 -7,166,000 -9,516,000 145,360,000 73,140,000 72,220,000 1,152,000

TTM Snapshot

Revenues TTM
$87,808,000
NetIncome TTM
$-10,412,000
OpCashFlow TTM
—
Assets (Latest)
$76,286,000
Forward EPS
$0.53

Peers — same industry

TickerNameMarket CapLastDaily %
TUNGF American Tungsten Corp. $41.57M $0.65 —
AGRZ Agroz Inc. $40.96M $1.89 —
PGZFF Pan Global Resources Inc. $40.96M $0.10 —
SGA SAGA COMMUNICATIONS INC $42.34M $6.66 —
PEW GrabAGun Digital Holdings Inc. $40.54M $1.37 —

News headlines (Yahoo Finance, 1h cache)

Harvard Bioscience Inc (HBIO) Q3 2026 Earnings Call Highlights: Revenue Growth Accelerates as ...
2026-11-11 09:03 · Yahoo
Harvard Bioscience, Inc. Q3 2026 Earnings Call Summary
2026-11-10 17:57 · Yahoo
Harvard Bioscience (HBIO) Q3 2026 Earnings Call Transcript
2026-11-10 17:28 · Yahoo
Harvard Bioscience: Q3 Earnings Snapshot
2026-11-10 12:19 · Yahoo
Harvard Bioscience Announces Third Quarter 2026 Financial Results
2026-11-10 12:00 · Yahoo
Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
2026-11-04 12:30 · Yahoo
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
2026-10-27 11:30 · Yahoo
Harvard Bioscience Announces Creation of Scientific Advisory Board
2026-10-06 20:05 · Yahoo
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript
2026-08-18 13:42 · Yahoo
Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ...
2026-08-11 19:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.